Prof Dharmarajan Sriram
Director
| Department of Pharmacy
Birla Institute of Technology & Sciences, Pilani
Telangana
Expertise:
Medicinal Chemistry
190
Publications
0
Projects
3487
Scopus Citations
3254
CrossRef
26 Years 1 Month Total Experience
Scopus
3,487
Citations
34
h-index
CrossRef
3,254
Citations
33
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
DBT-TATA INNOVATION FELLOWSHIP
2016
Department of Biotechnology, India
ICMR SHAKUNTALA AMIR CHAND PRIZE FOR RESEARCH IN TUBERCULOSIS
2011
Indian Council of Medical Research, India
Visiting Senior Researcher, under Brazilian Government "Science without Border" Program
2014
Brazilian Government
B.K. Birla & Sarala Birla Chair Professorship
2011
BITS-Pilani
Outstanding Researcher Award" For highest Scopus paper publication, citation and h- index in the year of 2018
2018
Career 360
YOUNG PHARMACY TEACHER AWARD
2006
Association of pharmacy teachers of India
INSA Senior visiting researcher
2013
Indian national science academy
Community & Membership
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Personal Details
Doctor of Philosophy
2000
Central Agricultural University, Imphal
Master of Pharmacy
1997
Central Agricultural University, Imphal
Bachelor of Pharmacy
1994
N/A
Director
Jan 2026 – Present
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Senior Professor
Aug 2000 – Jan 2026
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Medical and Health Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
Design synthesis and biological evaluation of novel mycobacterium tuberculosis pknB inhibitors
Structure prediction and molecular dynamics of open and closed conformations of pkm zeta for neurotherapeutic interventions
Design and synthesis of Aminopyrimidinimino Isatin Analogues as Novel -Non Nucleoside HIV-1 Reverse Transcriptase inhibitors with Broad - Spectrum antimicrobial properties
Design and synthesis of Novel Disubstituted Phenyl Semicarbazones and their analogues as anticonvulsants
Development of dna gyrase b and o acetyl serine sulfhydrylase inhibitors targeting mycobacterium tuberculosis
Development of human silent information regulator 1 modulators for treatment of cancer and metabolic disorders
Development of newer fused quinolone molecules against mycobacterium tuberculosis
Development of novel isatin-B-thiosemicarbazones for the treatment of HIV-TB co-infection
Investigation on structure - Activity relationship of the quinolone derivatives against mycobacterium tuberculosis
Thiazine derivatives: synthesis, anti tubercular activities and basic pharmacokinetic evaluation
Design and biological evaluation of novel staphylococcus aureus DNA GyrB inhibitors to treat pathogenic infections
Design and synthesis of novel anti-tubercular compounds
Development of novel DNA gyrase inhibitors targeting mycobacterium tuberculosis
Development of novel mycobactrium tuberculosis enoyl acyl carrier protein reductase inhibitors
Structure based drug design and in vitro biological screening for various enzymes of mycobacterium tuberculosis
Study of mycobacterium tuberculosis n-acetyl glucosamine-1-phosphate uridyltransferase
Synthesis and biological evaluation of bacterial dna gyrase inhibitors
Design, Synthesis and Evaluation of Novel N-Linked Quinoline and Naphthyridone Analogs as Potential Anti-Tubercular Agents
Development of Novel Cysteine Synthase M and Lysine Ɛ- Aminotransferase Inhibitors Targeting Dormant Stages of Mycobacterium tuberculosis
Design and Synthesis of Novel Mycobacterium tuberculosis Pantothenate Kinase and Glutamate Racemase Inhibitors
Synthesis and Antimycobacterial Evaluation of Novel Spiro/Fused Compounds
DESIGN AND SYNTHESIS OF PSEUDOMONAS…… GYRASE INHIBITORS
Design, Synthesis and Biological Assessment of Topoisomerase-I Inhibitors Targeting Mycobacterium tuberculosis
Targeting KARI of MTB
Development of Novel Anti-microbial Compounds Targeting Cysteine Synthase (CysM) and 3-Oxo-Acyl-ACP Reductase (FabG
M.Tuberculosis GlmU inhibitor
Vinay K Nandicoori
Vijay Soni
P. Yogeeswari
D.Sriram
-
Application No. :
3167
Filed :
01-10-2015
Published :
30-11--0001
Filed
NOVEL OXAZOLIDINE COMPOUND AND METHOD OF ITS PREPARATION
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE-PILANI
-
Patent No. :
14/2017
Filed :
01-10-2015
Published :
07-04-2017
Published
Cathepsin D inhibitors and compositions thereof for treating breast cancer.
Yogeeswari
P.
Sriram
D.
Hasitha
S.A.
Brahmam
M.
-
Application No. :
1763
Filed :
12-06-2015
Published :
30-11--0001
Filed
A method for preparing novel compounds for use as Cathepsin D enzyme inhibitoruseful in treatment of breast cancer
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE
PILANI
-
Patent No. :
52/2016
Filed :
12-06-2015
Published :
16-12-2016
Published
A Compound for treating inflammatory neuropathic pain and cancer.
Yogeeswari
P.
Sriram
D.
Madhubabu
B.
Brahmam
M
-
Application No. :
2945
Filed :
15-11-2014
Published :
30-11--0001
Filed
Novel compounds as modulators of AKT
Saketh
D.V.S.
Srikanth
V.
Yogeeswari
P.
Sriram
D
-
Application No. :
5707
Filed :
13-11-2014
Published :
30-11--0001
Filed
NOVEL N-SPIRO SUBSTITUTED COMPOUNDS
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Patent No. :
263536
Filed :
18-05-2009
Published :
21-08-2009
Granted
Scholarly Publications
Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humans
Design and synthesis of novel triazole linked pyrrole derivatives as potent Mycobacterium tuberculosis inhibitors
Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation
Synthesis, crystal structure and antimycobacterial activities of 4-indolyl-1,4-dihydropyridine derivatives possessing various ester groups
Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives
A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells
Polymer–gold nanoparticle composite films for topical application: Evaluation of physical properties and antibacterial activity
1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation
Open Access
Showing 1 to 8 of 190 publications